About this trial
This study is a prospective blind contrast between periscapular muscle thickness measured with MSUS in patients with early AS in comparison to patients with mechanical dyskinesis and to correlate it with EMG findings.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
treatment-naïve patients with ankylosing spondylitis (AS), who fulfilled the Assessment of Spondylarthritis Society (ASAS) criteria for axial spondyloarthritis (ax-SpA)
Inclusion criterion for the second group (non-AS individuals) was patients complaining of discomfort upon activity.
Disqualifiers
patients with a history of local trauma
and/or surgical intervention,
neuromascular deficits,
chronic chest disease and
Trial population
* The first group: treatment-naïve patients with ankylosing spondylitis (AS), who fulfil the Assessment of Spondylarthritis Society (ASAS) criteria for axial spondyloarthritis (ax-SpA) * The second group (non-AS individuals) : patients complaining of discomfort upon activity.
Trial design
Other
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
periscapular muscle thickness measured with MSUS in patients with early ASversus patients with mechanical dyskinesis
contrast between periscapular muscle thickness measured with MSUS in patients with early AS in comparison to patients with mechanical dyskinesis and to correlate it with EMG findings.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.